These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24319831)

  • 21. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy.
    Nelson SP; Kothari S; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    J Med Econ; 2009; 12(4):348-55. PubMed ID: 19827992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acid inhibition and infections outside the gastrointestinal tract.
    Vakil N
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S17-20. PubMed ID: 19262541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of histamine-2 receptor antagonists.
    van der Pol R; Langendam M; Benninga M; van Wijk M; Tabbers M
    JAMA Pediatr; 2014 Oct; 168(10):947-54. PubMed ID: 25133940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
    Malcolm WF; Gantz M; Martin RJ; Goldstein RF; Goldberg RN; Cotten CM;
    Pediatrics; 2008 Jan; 121(1):22-7. PubMed ID: 18166553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current role of laparoscopic surgery for gastroesophageal reflux disease in infants and children.
    Lobe TE
    Surg Endosc; 2007 Feb; 21(2):167-74. PubMed ID: 17200908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
    Tjon JA; Pe M; Soscia J; Mahant S
    Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy.
    Colletti RB; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S7-S11. PubMed ID: 14685071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal and proton pump inhibitor-mediated gastrin levels in infants 1 to 11 months old.
    Treem W; Hu P; Sloan S
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):520-6. PubMed ID: 23689261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of anti-reflux medications in infants under 1 year of age: a retrospective drug utilization study using national prescription reimbursement data.
    O'Reilly D; Conway R; O'Connor L; Fitzpatrick P
    Eur J Pediatr; 2020 Dec; 179(12):1963-1967. PubMed ID: 33051717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid-Suppressive Drug Use During Pregnancy and the Risk of Childhood Asthma: A Meta-analysis.
    Lai T; Wu M; Liu J; Luo M; He L; Wang X; Wu B; Ying S; Chen Z; Li W; Shen H
    Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29326337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
    Malcolm WF; Cotten CM
    Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study.
    Andersen AB; Erichsen R; Farkas DK; Mehnert F; Ehrenstein V; Sørensen HT
    Aliment Pharmacol Ther; 2012 May; 35(10):1190-8. PubMed ID: 22443179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy and drugs used in gastro-oesophageal reflux.
    Prescrire Int; 2015 Dec; 24(166):297-9. PubMed ID: 26788579
    [No Abstract]   [Full Text] [Related]  

  • 34. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
    Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood.
    Mitre E; Susi A; Kropp LE; Schwartz DJ; Gorman GH; Nylund CM
    JAMA Pediatr; 2018 Jun; 172(6):e180315. PubMed ID: 29610864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors and Raynaud's phenomenon: is there a link?
    Khouri C; Revol B; Cracowski JL; Roustit M
    Br J Clin Pharmacol; 2018 Oct; 84(10):2443-2444. PubMed ID: 30003585
    [No Abstract]   [Full Text] [Related]  

  • 38. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do pediatricians apply the 2009 NASPGHAN-ESPGHAN guidelines for the diagnosis and management of gastroesophageal reflux after being trained?
    Quitadamo P; Urbonas V; Papadopoulou A; Roman E; Pavkov DJ; Orel R; Dias JA; Kostovski A; Miele E; Villani A; Staiano A
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):356-9. PubMed ID: 24762458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on the latest chemical therapies for reflux esophagitis in children.
    Bardou M; Fortinsky KJ; Chapelle N; Luu M; Barkun A
    Expert Opin Pharmacother; 2019 Feb; 20(2):231-239. PubMed ID: 30496693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.